iBio Inc. (IBIO)
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
enGene Announces Proposed Public Offering of Common Shares
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
enGene Announces Proposed Public Offering of Common Shares
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Jushi Holdings and Real Housewives Star Stacey Rusch Bring Shayo to Nevada Adult-Use Market After Virginia Success
Indivior Notification